Brunei vs South-East Asia (WHO region): HIV-positive TB patients on ART (antiretroviral therapy)
Brunei
100.0%
in 2024
South-East Asia (WHO region)
94.0%
in 2024
Brunei rank
1st
South-East Asia (WHO region) rank
4th
HIV-positive TB patients on ART (antiretroviral therapy) over time
- Brunei
- South-East Asia (WHO region)
How they compare
Brunei currently reports 100.0% against 94.0% in South-East Asia (WHO region), a difference of 6.0%.
That makes Brunei's figure about 1.1 times South-East Asia (WHO region)'s.
Across all 15 years both countries report, Brunei has been ahead every year.
Brunei ranks 1st and South-East Asia (WHO region) ranks 4th of 144 countries.
Brunei has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Brunei | South-East Asia (WHO region) | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 100.0% | 55.0% | 45.0% | Brunei |
| 2010s | 100.0% | 74.5% | 25.5% | Brunei |
| 2020s | 100.0% | 92.2% | 7.8% | Brunei |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on art (antiretroviral therapy), Brunei or South-East Asia (WHO region)?
- Brunei, at 100.0% against 94.0% in South-East Asia (WHO region) as of 2024.
- What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between Brunei and South-East Asia (WHO region)?
- 6.0%, with Brunei ahead.
- How many years of comparable data are there for Brunei and South-East Asia (WHO region)?
- 15 years are reported by both, from 2003 to 2024.
- How do Brunei and South-East Asia (WHO region) rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
- Brunei ranks 1st and South-East Asia (WHO region) ranks 4th of 144 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.